nanofitins for type 1 diabetes(Affilogic)

N/A

Report date: 2025/03/20 14:56:43

Base Information

Drug Namenanofitins for type 1 diabetes(Affilogic)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffilogic Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAffilogic Laboratories
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A